(R)-tert-Butyl 2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate

Catalog No. :
ACLCIM461
CAS No. :
203056-15-9
Molecular Formula :
C13H24N2O4
Molecular Weight :
272.35

IUPAC Name:tert-butyl (R)-2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate

(R)-tert-Butyl 2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate
IUPAC Nametert-butyl (R)-2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate
MDL No.MFCD11975768
Molecular FormulaC13H24N2O4
Molecular Weight272.35
SMILESO=C(N1[C@@H](C(N(OC)C)=O)CCCC1)OC(C)(C)C
InChI KeyBYYHZPIPLAIBOA-SNVBAGLBSA-N
Synonym(R)-TERT-BUTYL 2-(METHOXY(METHYL)CARBAMOYL)PIPERIDINE-1-CARBOXYLATE;2-[[methoxy(methyl)amino]-oxomethyl]-1-piperidinecarboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 2-[(methoxymethylamino)carbonyl]-, 1,1-dimethylethyl ester, (2R)-;1-Boc-(2R)-(N-methoxy-N-methylcarbamoyl)piperidine;(R)-1-Boc-2-[methoxy(methyl)carbamoyl]piperidine;tert-butyl (R)-2-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate
CAS No.203056-15-9

Synthetic Route by SureRoute

1. ACLCIM461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAZK735 route compound structure diagram
    ACXAZK73528697-17-8 In Stock
  2. Plus
  3. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  4. Then
  5. ACLCIM461 route product structure diagram
    ACLCIM461203056-15-9
Inquiry

2. ACLCIM461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLCIM461 route product structure diagram
    ACLCIM461203056-15-9
Inquiry

Comments (0)